Arcadia Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-141
Closed -$25K 103
2022
Q2
$25K Buy
+141
New +$25.1K 0.02% 59
2021
Q3
Sell
-17
Closed -$2.8K 177
2021
Q2
$2.8K Buy
+17
New +$2.81K ﹤0.01% 108
2021
Q1
Sell
-10
Closed -$1.57K 109
2020
Q4
$1.57K Hold
10
﹤0.01% 100
2020
Q3
$1.49K Hold
10
﹤0.01% 94
2020
Q2
$1.41K Hold
10
﹤0.01% 67
2020
Q1
$1.31K Hold
10
﹤0.01% 69
2019
Q4
$1.46K Buy
+10
New +$1.36K ﹤0.01% 57

Other funds holding JNJ

Arcadia Investment Advisors's JNJ Position: Q3 2022 in Review

Arcadia Investment Advisors sold out of Johnson & Johnson (JNJ) in Q3 2022, closing a stake of 141 shares — an estimated $25K sold.

Arcadia Investment Advisors first reported a position in JNJ in Q4 2019 and held it in 7 quarters. The position peaked at $25K in Q2 2022. 3,622 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.

  • Arcadia Investment Advisors reported no remaining Johnson & Johnson position as of Q3 2022 after selling out during the quarter.
  • Arcadia Investment Advisors sold 141 Johnson & Johnson shares in Q3 2022, an estimated $25K.
  • Arcadia Investment Advisors first reported a position in Johnson & Johnson in Q4 2019 and held it in 7 quarters.
  • Arcadia Investment Advisors's Johnson & Johnson position peaked at $25K in Q2 2022.
  • 3,622 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.

Based on Arcadia Investment Advisors's 13F filing for Q3 2022, filed 19 Dec 2024.